img

Global Anti-Inflammatory Cytokine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-Inflammatory Cytokine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Anti-Inflammatory Cytokine is categorised as a large group of peptides, glycoproteins and proteins that are present into specific cells in the immune system. Cytokines are produced in the body may have different origins like lymphocytes, monocytes and others. Anti-inflammatory cytokines are regulatory molecule for a pro-inflammation response from cytokines. Inflammatory cytokines can lead to cytokine storm causing nerve-injury/inflammation-induced central sensitization, atherosclerosis or cancer. 
Anti-Inflammatory Cytokine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-Inflammatory Cytokine market is projected to reach US$ 40060 million in 2029, increasing from US$ 25800 million in 2022, with the CAGR of 6.6% during the period of 2024 to 2029. Demand from Cardiovascular Diseases and Osteoarthritis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-Inflammatory Cytokine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Anti-Inflammatory Cytokine key manufacturers include Merck KGaA, Eli Lilly and Company, Pfizer Inc., Sanofi S.A., Novartis AG, Hoffmann-La Roche Ltd., Lonza Group Ltd., Thermo Fisher Scientific and Meridian Bioscience Inc., etc. Merck KGaA, Eli Lilly and Company, Pfizer Inc. are top 3 players and held % sales share in total in 2022.
Anti-Inflammatory Cytokine can be divided into Oral, Intravenous and Others,, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022.
Anti-Inflammatory Cytokine is widely used in various fields, such as Cardiovascular Diseases, Osteoarthritis and Others,, etc. Cardiovascular Diseases provides greatest supports to the Anti-Inflammatory Cytokine industry development. In 2022, global % sales of Anti-Inflammatory Cytokine went into Cardiovascular Diseases filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Inflammatory Cytokine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck KGaA
Eli Lilly and Company
Pfizer Inc.
Sanofi S.A.
Novartis AG
Hoffmann-La Roche Ltd.
Lonza Group Ltd.
Thermo Fisher Scientific
Meridian Bioscience Inc.
General Electric Company
Abcam PLC
GenScript Biotech Corp
Applied Biological Materials Inc.
Randox Laboratories
Segment by Type
Oral
Intravenous
Others

Segment by Application


Cardiovascular Diseases
Osteoarthritis
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Anti-Inflammatory Cytokine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-Inflammatory Cytokine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-Inflammatory Cytokine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Anti-Inflammatory Cytokine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-Inflammatory Cytokine introduction, etc. Anti-Inflammatory Cytokine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Anti-Inflammatory Cytokine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Anti-Inflammatory Cytokine Market Overview
1.1 Anti-Inflammatory Cytokine Product Overview
1.2 Anti-Inflammatory Cytokine Market Segment by Type
1.2.1 Oral
1.2.2 Intravenous
1.2.3 Others
1.3 Global Anti-Inflammatory Cytokine Market Size by Type
1.3.1 Global Anti-Inflammatory Cytokine Market Size Overview by Type (2018-2029)
1.3.2 Global Anti-Inflammatory Cytokine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anti-Inflammatory Cytokine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Inflammatory Cytokine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anti-Inflammatory Cytokine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anti-Inflammatory Cytokine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anti-Inflammatory Cytokine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anti-Inflammatory Cytokine Sales Breakdown by Type (2018-2024)
2 Global Anti-Inflammatory Cytokine Market Competition by Company
2.1 Global Top Players by Anti-Inflammatory Cytokine Sales (2018-2024)
2.2 Global Top Players by Anti-Inflammatory Cytokine Revenue (2018-2024)
2.3 Global Top Players by Anti-Inflammatory Cytokine Price (2018-2024)
2.4 Global Top Manufacturers Anti-Inflammatory Cytokine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Inflammatory Cytokine Market Competitive Situation and Trends
2.5.1 Anti-Inflammatory Cytokine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Inflammatory Cytokine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Inflammatory Cytokine as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Inflammatory Cytokine Market
2.8 Key Manufacturers Anti-Inflammatory Cytokine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Inflammatory Cytokine Status and Outlook by Region
3.1 Global Anti-Inflammatory Cytokine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anti-Inflammatory Cytokine Historic Market Size by Region
3.2.1 Global Anti-Inflammatory Cytokine Sales in Volume by Region (2018-2024)
3.2.2 Global Anti-Inflammatory Cytokine Sales in Value by Region (2018-2024)
3.2.3 Global Anti-Inflammatory Cytokine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anti-Inflammatory Cytokine Forecasted Market Size by Region
3.3.1 Global Anti-Inflammatory Cytokine Sales in Volume by Region (2024-2029)
3.3.2 Global Anti-Inflammatory Cytokine Sales in Value by Region (2024-2029)
3.3.3 Global Anti-Inflammatory Cytokine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anti-Inflammatory Cytokine by Application
4.1 Anti-Inflammatory Cytokine Market Segment by Application
4.1.1 Cardiovascular Diseases
4.1.2 Osteoarthritis
4.1.3 Others
4.2 Global Anti-Inflammatory Cytokine Market Size by Application
4.2.1 Global Anti-Inflammatory Cytokine Market Size Overview by Application (2018-2029)
4.2.2 Global Anti-Inflammatory Cytokine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Anti-Inflammatory Cytokine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Inflammatory Cytokine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Anti-Inflammatory Cytokine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Anti-Inflammatory Cytokine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Anti-Inflammatory Cytokine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Anti-Inflammatory Cytokine Sales Breakdown by Application (2018-2024)
5 North America Anti-Inflammatory Cytokine by Country
5.1 North America Anti-Inflammatory Cytokine Historic Market Size by Country
5.1.1 North America Anti-Inflammatory Cytokine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anti-Inflammatory Cytokine Sales in Volume by Country (2018-2024)
5.1.3 North America Anti-Inflammatory Cytokine Sales in Value by Country (2018-2024)
5.2 North America Anti-Inflammatory Cytokine Forecasted Market Size by Country
5.2.1 North America Anti-Inflammatory Cytokine Sales in Volume by Country (2024-2029)
5.2.2 North America Anti-Inflammatory Cytokine Sales in Value by Country (2024-2029)
6 Europe Anti-Inflammatory Cytokine by Country
6.1 Europe Anti-Inflammatory Cytokine Historic Market Size by Country
6.1.1 Europe Anti-Inflammatory Cytokine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anti-Inflammatory Cytokine Sales in Volume by Country (2018-2024)
6.1.3 Europe Anti-Inflammatory Cytokine Sales in Value by Country (2018-2024)
6.2 Europe Anti-Inflammatory Cytokine Forecasted Market Size by Country
6.2.1 Europe Anti-Inflammatory Cytokine Sales in Volume by Country (2024-2029)
6.2.2 Europe Anti-Inflammatory Cytokine Sales in Value by Country (2024-2029)
7 Asia-Pacific Anti-Inflammatory Cytokine by Region
7.1 Asia-Pacific Anti-Inflammatory Cytokine Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Inflammatory Cytokine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anti-Inflammatory Cytokine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anti-Inflammatory Cytokine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anti-Inflammatory Cytokine Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Inflammatory Cytokine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anti-Inflammatory Cytokine Sales in Value by Region (2024-2029)
8 Latin America Anti-Inflammatory Cytokine by Country
8.1 Latin America Anti-Inflammatory Cytokine Historic Market Size by Country
8.1.1 Latin America Anti-Inflammatory Cytokine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anti-Inflammatory Cytokine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anti-Inflammatory Cytokine Sales in Value by Country (2018-2024)
8.2 Latin America Anti-Inflammatory Cytokine Forecasted Market Size by Country
8.2.1 Latin America Anti-Inflammatory Cytokine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anti-Inflammatory Cytokine Sales in Value by Country (2024-2029)
9 Middle East and Africa Anti-Inflammatory Cytokine by Country
9.1 Middle East and Africa Anti-Inflammatory Cytokine Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Inflammatory Cytokine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anti-Inflammatory Cytokine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anti-Inflammatory Cytokine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anti-Inflammatory Cytokine Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Inflammatory Cytokine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anti-Inflammatory Cytokine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck KGaA
10.1.1 Merck KGaA Company Information
10.1.2 Merck KGaA Introduction and Business Overview
10.1.3 Merck KGaA Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck KGaA Anti-Inflammatory Cytokine Products Offered
10.1.5 Merck KGaA Recent Development
10.2 Eli Lilly and Company
10.2.1 Eli Lilly and Company Company Information
10.2.2 Eli Lilly and Company Introduction and Business Overview
10.2.3 Eli Lilly and Company Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Eli Lilly and Company Anti-Inflammatory Cytokine Products Offered
10.2.5 Eli Lilly and Company Recent Development
10.3 Pfizer Inc.
10.3.1 Pfizer Inc. Company Information
10.3.2 Pfizer Inc. Introduction and Business Overview
10.3.3 Pfizer Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Pfizer Inc. Anti-Inflammatory Cytokine Products Offered
10.3.5 Pfizer Inc. Recent Development
10.4 Sanofi S.A.
10.4.1 Sanofi S.A. Company Information
10.4.2 Sanofi S.A. Introduction and Business Overview
10.4.3 Sanofi S.A. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sanofi S.A. Anti-Inflammatory Cytokine Products Offered
10.4.5 Sanofi S.A. Recent Development
10.5 Novartis AG
10.5.1 Novartis AG Company Information
10.5.2 Novartis AG Introduction and Business Overview
10.5.3 Novartis AG Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novartis AG Anti-Inflammatory Cytokine Products Offered
10.5.5 Novartis AG Recent Development
10.6 Hoffmann-La Roche Ltd.
10.6.1 Hoffmann-La Roche Ltd. Company Information
10.6.2 Hoffmann-La Roche Ltd. Introduction and Business Overview
10.6.3 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Products Offered
10.6.5 Hoffmann-La Roche Ltd. Recent Development
10.7 Lonza Group Ltd.
10.7.1 Lonza Group Ltd. Company Information
10.7.2 Lonza Group Ltd. Introduction and Business Overview
10.7.3 Lonza Group Ltd. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Lonza Group Ltd. Anti-Inflammatory Cytokine Products Offered
10.7.5 Lonza Group Ltd. Recent Development
10.8 Thermo Fisher Scientific
10.8.1 Thermo Fisher Scientific Company Information
10.8.2 Thermo Fisher Scientific Introduction and Business Overview
10.8.3 Thermo Fisher Scientific Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Thermo Fisher Scientific Anti-Inflammatory Cytokine Products Offered
10.8.5 Thermo Fisher Scientific Recent Development
10.9 Meridian Bioscience Inc.
10.9.1 Meridian Bioscience Inc. Company Information
10.9.2 Meridian Bioscience Inc. Introduction and Business Overview
10.9.3 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Products Offered
10.9.5 Meridian Bioscience Inc. Recent Development
10.10 General Electric Company
10.10.1 General Electric Company Company Information
10.10.2 General Electric Company Introduction and Business Overview
10.10.3 General Electric Company Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 General Electric Company Anti-Inflammatory Cytokine Products Offered
10.10.5 General Electric Company Recent Development
10.11 Abcam PLC
10.11.1 Abcam PLC Company Information
10.11.2 Abcam PLC Introduction and Business Overview
10.11.3 Abcam PLC Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Abcam PLC Anti-Inflammatory Cytokine Products Offered
10.11.5 Abcam PLC Recent Development
10.12 GenScript Biotech Corp
10.12.1 GenScript Biotech Corp Company Information
10.12.2 GenScript Biotech Corp Introduction and Business Overview
10.12.3 GenScript Biotech Corp Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 GenScript Biotech Corp Anti-Inflammatory Cytokine Products Offered
10.12.5 GenScript Biotech Corp Recent Development
10.13 Applied Biological Materials Inc.
10.13.1 Applied Biological Materials Inc. Company Information
10.13.2 Applied Biological Materials Inc. Introduction and Business Overview
10.13.3 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Products Offered
10.13.5 Applied Biological Materials Inc. Recent Development
10.14 Randox Laboratories
10.14.1 Randox Laboratories Company Information
10.14.2 Randox Laboratories Introduction and Business Overview
10.14.3 Randox Laboratories Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Randox Laboratories Anti-Inflammatory Cytokine Products Offered
10.14.5 Randox Laboratories Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Inflammatory Cytokine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Inflammatory Cytokine Industrial Chain Analysis
11.4 Anti-Inflammatory Cytokine Market Dynamics
11.4.1 Anti-Inflammatory Cytokine Industry Trends
11.4.2 Anti-Inflammatory Cytokine Market Drivers
11.4.3 Anti-Inflammatory Cytokine Market Challenges
11.4.4 Anti-Inflammatory Cytokine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Inflammatory Cytokine Distributors
12.3 Anti-Inflammatory Cytokine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Oral
Table 2. Major Company of Intravenous
Table 3. Major Company of Others
Table 4. Global Anti-Inflammatory Cytokine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Anti-Inflammatory Cytokine Sales by Type (2018-2024) & (K Units)
Table 6. Global Anti-Inflammatory Cytokine Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Anti-Inflammatory Cytokine Sales by Type (2018-2024) & (US& Million)
Table 8. Global Anti-Inflammatory Cytokine Market Share in Value by Type (2018-2024)
Table 9. Global Anti-Inflammatory Cytokine Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Anti-Inflammatory Cytokine Sales by Type (2024-2029) & (K Units)
Table 11. Global Anti-Inflammatory Cytokine Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Anti-Inflammatory Cytokine Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Anti-Inflammatory Cytokine Sales Market Share in Value by Type (2024-2029)
Table 14. Global Anti-Inflammatory Cytokine Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Anti-Inflammatory Cytokine Sales by Type (2018-2024) & (K Units)
Table 16. North America Anti-Inflammatory Cytokine Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Anti-Inflammatory Cytokine Sales (K Units) by Type (2018-2024)
Table 18. Europe Anti-Inflammatory Cytokine Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Anti-Inflammatory Cytokine Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Anti-Inflammatory Cytokine Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Anti-Inflammatory Cytokine Sales (K Units) by Type (2018-2024)
Table 22. Latin America Anti-Inflammatory Cytokine Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Anti-Inflammatory Cytokine Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Anti-Inflammatory Cytokine Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Anti-Inflammatory Cytokine Sales by Company (2018-2024) & (K Units)
Table 26. Global Anti-Inflammatory Cytokine Sales Share by Company (2018-2024)
Table 27. Global Anti-Inflammatory Cytokine Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Anti-Inflammatory Cytokine Revenue Share by Company (2018-2024)
Table 29. Global Market Anti-Inflammatory Cytokine Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Anti-Inflammatory Cytokine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Anti-Inflammatory Cytokine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Inflammatory Cytokine as of 2022)
Table 33. Date of Key Manufacturers Enter into Anti-Inflammatory Cytokine Market
Table 34. Key Manufacturers Anti-Inflammatory Cytokine Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Anti-Inflammatory Cytokine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Anti-Inflammatory Cytokine Sales by Region (2018-2024) & (K Units)
Table 38. Global Anti-Inflammatory Cytokine Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Anti-Inflammatory Cytokine Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Anti-Inflammatory Cytokine Sales Market Share in Value by Region (2018-2024)
Table 41. Global Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Anti-Inflammatory Cytokine Sales by Region (2024-2029) & (K Units)
Table 43. Global Anti-Inflammatory Cytokine Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Anti-Inflammatory Cytokine Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Anti-Inflammatory Cytokine Sales Market Share in Value by Region (2024-2029)
Table 46. Global Anti-Inflammatory Cytokine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Anti-Inflammatory Cytokine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Anti-Inflammatory Cytokine Sales by Application (2018-2024) & (K Units)
Table 49. Global Anti-Inflammatory Cytokine Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Anti-Inflammatory Cytokine Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Anti-Inflammatory Cytokine Sales Market Share in Value by Application (2018-2024)
Table 52. Global Anti-Inflammatory Cytokine Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Anti-Inflammatory Cytokine Sales by Application (2024-2029) & (K Units)
Table 54. Global Anti-Inflammatory Cytokine Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Anti-Inflammatory Cytokine Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Anti-Inflammatory Cytokine Sales Market Share in Value by Application (2024-2029)
Table 57. Global Anti-Inflammatory Cytokine Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Anti-Inflammatory Cytokine Sales by Application (2018-2024) (K Units)
Table 59. North America Anti-Inflammatory Cytokine Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Anti-Inflammatory Cytokine Sales by Application (2018-2024) (K Units)
Table 61. Europe Anti-Inflammatory Cytokine Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Anti-Inflammatory Cytokine Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Anti-Inflammatory Cytokine Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Anti-Inflammatory Cytokine Sales by Application (2018-2024) (K Units)
Table 65. Latin America Anti-Inflammatory Cytokine Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Anti-Inflammatory Cytokine Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Anti-Inflammatory Cytokine Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Anti-Inflammatory Cytokine Sales by Country (2018-2024) & (K Units)
Table 69. North America Anti-Inflammatory Cytokine Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Anti-Inflammatory Cytokine Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Anti-Inflammatory Cytokine Sales Market Share in Value by Country (2018-2024)
Table 72. North America Anti-Inflammatory Cytokine Sales by Country (2024-2029) & (K Units)
Table 73. North America Anti-Inflammatory Cytokine Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Anti-Inflammatory Cytokine Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Anti-Inflammatory Cytokine Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Anti-Inflammatory Cytokine Sales by Country (2018-2024) & (K Units)
Table 77. Europe Anti-Inflammatory Cytokine Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Anti-Inflammatory Cytokine Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Anti-Inflammatory Cytokine Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Anti-Inflammatory Cytokine Sales by Country (2024-2029) & (K Units)
Table 81. Europe Anti-Inflammatory Cytokine Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Anti-Inflammatory Cytokine Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Anti-Inflammatory Cytokine Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Anti-Inflammatory Cytokine Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Anti-Inflammatory Cytokine Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Anti-Inflammatory Cytokine Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Anti-Inflammatory Cytokine Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Anti-Inflammatory Cytokine Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Anti-Inflammatory Cytokine Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Anti-Inflammatory Cytokine Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Anti-Inflammatory Cytokine Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Anti-Inflammatory Cytokine Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Anti-Inflammatory Cytokine Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Anti-Inflammatory Cytokine Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Anti-Inflammatory Cytokine Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Anti-Inflammatory Cytokine Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Anti-Inflammatory Cytokine Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Anti-Inflammatory Cytokine Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Anti-Inflammatory Cytokine Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Anti-Inflammatory Cytokine Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Anti-Inflammatory Cytokine Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Anti-Inflammatory Cytokine Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Anti-Inflammatory Cytokine Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Anti-Inflammatory Cytokine Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Anti-Inflammatory Cytokine Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Anti-Inflammatory Cytokine Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Anti-Inflammatory Cytokine Sales Market Share in Value by Country (2024-2029)
Table 108. Merck KGaA Company Information
Table 109. Merck KGaA Introduction and Business Overview
Table 110. Merck KGaA Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Merck KGaA Anti-Inflammatory Cytokine Product
Table 112. Merck KGaA Recent Development
Table 113. Eli Lilly and Company Company Information
Table 114. Eli Lilly and Company Introduction and Business Overview
Table 115. Eli Lilly and Company Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Eli Lilly and Company Anti-Inflammatory Cytokine Product
Table 117. Eli Lilly and Company Recent Development
Table 118. Pfizer Inc. Company Information
Table 119. Pfizer Inc. Introduction and Business Overview
Table 120. Pfizer Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Pfizer Inc. Anti-Inflammatory Cytokine Product
Table 122. Pfizer Inc. Recent Development
Table 123. Sanofi S.A. Company Information
Table 124. Sanofi S.A. Introduction and Business Overview
Table 125. Sanofi S.A. Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Sanofi S.A. Anti-Inflammatory Cytokine Product
Table 127. Sanofi S.A. Recent Development
Table 128. Novartis AG Company Information
Table 129. Novartis AG Introduction and Business Overview
Table 130. Novartis AG Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Novartis AG Anti-Inflammatory Cytokine Product
Table 132. Novartis AG Recent Development
Table 133. Hoffmann-La Roche Ltd. Company Information
Table 134. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 135. Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Product
Table 137. Hoffmann-La Roche Ltd. Recent Development
Table 138. Lonza Group Ltd. Company Information
Table 139. Lonza Group Ltd. Introduction and Business Overview
Table 140. Lonza Group Ltd. Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Lonza Group Ltd. Anti-Inflammatory Cytokine Product
Table 142. Lonza Group Ltd. Recent Development
Table 143. Thermo Fisher Scientific Company Information
Table 144. Thermo Fisher Scientific Introduction and Business Overview
Table 145. Thermo Fisher Scientific Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Thermo Fisher Scientific Anti-Inflammatory Cytokine Product
Table 147. Thermo Fisher Scientific Recent Development
Table 148. Meridian Bioscience Inc. Company Information
Table 149. Meridian Bioscience Inc. Introduction and Business Overview
Table 150. Meridian Bioscience Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Meridian Bioscience Inc. Anti-Inflammatory Cytokine Product
Table 152. Meridian Bioscience Inc. Recent Development
Table 153. General Electric Company Company Information
Table 154. General Electric Company Introduction and Business Overview
Table 155. General Electric Company Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. General Electric Company Anti-Inflammatory Cytokine Product
Table 157. General Electric Company Recent Development
Table 158. Abcam PLC Company Information
Table 159. Abcam PLC Introduction and Business Overview
Table 160. Abcam PLC Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Abcam PLC Anti-Inflammatory Cytokine Product
Table 162. Abcam PLC Recent Development
Table 163. GenScript Biotech Corp Company Information
Table 164. GenScript Biotech Corp Introduction and Business Overview
Table 165. GenScript Biotech Corp Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. GenScript Biotech Corp Anti-Inflammatory Cytokine Product
Table 167. GenScript Biotech Corp Recent Development
Table 168. Applied Biological Materials Inc. Company Information
Table 169. Applied Biological Materials Inc. Introduction and Business Overview
Table 170. Applied Biological Materials Inc. Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Applied Biological Materials Inc. Anti-Inflammatory Cytokine Product
Table 172. Applied Biological Materials Inc. Recent Development
Table 173. Randox Laboratories Company Information
Table 174. Randox Laboratories Introduction and Business Overview
Table 175. Randox Laboratories Anti-Inflammatory Cytokine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. Randox Laboratories Anti-Inflammatory Cytokine Product
Table 177. Randox Laboratories Recent Development
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Anti-Inflammatory Cytokine Market Trends
Table 181. Anti-Inflammatory Cytokine Market Drivers
Table 182. Anti-Inflammatory Cytokine Market Challenges
Table 183. Anti-Inflammatory Cytokine Market Restraints
Table 184. Anti-Inflammatory Cytokine Distributors List
Table 185. Anti-Inflammatory Cytokine Downstream Customers
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Inflammatory Cytokine Product Picture
Figure 2. Global Anti-Inflammatory Cytokine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Anti-Inflammatory Cytokine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Anti-Inflammatory Cytokine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Oral
Figure 6. Global Oral Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Intravenous
Figure 8. Global Intravenous Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Anti-Inflammatory Cytokine Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Anti-Inflammatory Cytokine Sales Market Share by Type in 2022 & 2029
Figure 13. North America Anti-Inflammatory Cytokine Sales Market Share in Volume by Type in 2022
Figure 14. North America Anti-Inflammatory Cytokine Sales Market Share in Value by Type in 2022
Figure 15. Europe Anti-Inflammatory Cytokine Sales Market Share in Volume by Type in 2022
Figure 16. Europe Anti-Inflammatory Cytokine Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Anti-Inflammatory Cytokine Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Anti-Inflammatory Cytokine Sales Market Share in Value by Type in 2022
Figure 19. Latin America Anti-Inflammatory Cytokine Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Anti-Inflammatory Cytokine Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Anti-Inflammatory Cytokine Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Anti-Inflammatory Cytokine Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Inflammatory Cytokine Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Inflammatory Cytokine Revenue in 2022
Figure 25. Anti-Inflammatory Cytokine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Cardiovascular Diseases
Figure 27. Global Cardiovascular Diseases Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Osteoarthritis
Figure 29. Global Osteoarthritis Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Anti-Inflammatory Cytokine Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Anti-Inflammatory Cytokine Sales Market Share by Application in 2022 & 2029
Figure 34. North America Anti-Inflammatory Cytokine Sales Market Share in Volume by Application in 2022
Figure 35. North America Anti-Inflammatory Cytokine Sales Market Share in Value by Application in 2022
Figure 36. Europe Anti-Inflammatory Cytokine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Anti-Inflammatory Cytokine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Anti-Inflammatory Cytokine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Anti-Inflammatory Cytokine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Anti-Inflammatory Cytokine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Anti-Inflammatory Cytokine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Anti-Inflammatory Cytokine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Anti-Inflammatory Cytokine Manufacturing Cost Structure
Figure 45. Anti-Inflammatory Cytokine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries